"Data from the third prespecified interim analysis presented here provides further support for olaparib's benefits in patients with high-risk, HER2-negative breast cancer withgermline mutationsin BRCA1 or BRCA2," said Garber. After a median follow-up of 6.1 years, patients treated with olaparib c...
Citations may include links to full-text content from PubMed Central and publisher web sites.doi:10.1097/01.JNR.0000347587.85457.5fI-Chuan Li台灣護理學會Journal of Nursing Research
CANCER patientsONCOLOGISTSLONG-term health careMEDICAREMEDICAL careThe article focuses on long-term clinical care for cancer patients. It states that the data from surveillance, epidemiology, and end results were used to describe the physicians' specialties that render care for Medicare recipients ...
The researchers found no increase in secondary cancer incidence and only minor increases in heart problems, confirming trastuzumab’s long-term safety, the study noted. “This long follow-up of patients shows that we have really altered the natural history of this disease,” Edith A. Perez, MD...
Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data Long-term medical-care costs related to prostate cancer: estimates from linked SEER-Medicare data. Prostate Cancer PD. 2010;13(3): 278-84... ...
There remains an unmet need for effective and well-tolerated long-term maintenance treatment options for patients with recurrent ovarian cancer to maintain quality of life and delay the need for further chemotherapy, particularly after response.
Long-term care benefits and services in Europe. Introduction:With numbers of older people rising throughout the developed countries [1], long-term care (LTC) services for the elderly gain in importance. ... MPY Landauer - 《Gerontology International Journal of Experimental & Clinical Gerontology》...
January 27, 2012 (San Francisco, California) — Adjuvant therapy with capecitabine plus oxaliplatin (XELOX) significantly improves overall survival, compared with bolus 5-fluorouracil/leucovorin (5-FU/LV), in patients with resected stage III colon cancer, even 6 to 7 years after the completion of...
Long-term impact of cancer scores was higher among the patients who had an EC recurrence or second cancer. Conclusions More than 7 years after treatment, EBRT patients reported more bowel symptoms with impact on daily activities, and a trend for more urinary symptoms, without impact on overall ...
Providing SCP using an information website application for women with breast cancer can decrease unmet needs, fear of recurrence, and improve quality of life during short-term and long-term use. Web-based information that provides survivorship care plans for breast cancer survivors are beneficial. ...